纳米凝胶
阳离子聚合
化学
生物物理学
PEG比率
聚乙二醇
核酸
药物输送
材料科学
生物化学
高分子化学
有机化学
生物
财务
经济
作者
Alexander Fuchs,Christian Czysch,Konrad Maxeiner,Pia Winterwerber,Sascha Schmitt,Judith Stickdorn,Zifu Zhong,Carolina Medina‐Montano,Hans Joachim Räder,Matthias Bros,Bruno G. De Geest,Kaloian Koynov,Stephan Grabbe,Lutz Nuhn
出处
期刊:Small
[Wiley]
日期:2024-12-01
标识
DOI:10.1002/smll.202406082
摘要
Abstract Cationic, core‐crosslinked nanogel particles are prepared from synthetic biodegradable materials. These fully hydrophilic nanogels offer superior customizability compared to common lipid nanoparticles, thereby circumventing intrinsic immune stimulatory properties. Electrostatic loading allows for complexation of nucleic acids including the immune stimulatory Toll‐like receptor 9 (TLR9) agonistCpG‐ODN (cytidine‐phosphate‐guanosine oligodeoxynucleotide). Only when complexed inside nanogels, one can control CpG‐ODN's biodistribution, prevent systemic toxicity, and increase bioavailability at target locations. Nanogels are prepared from cyclic aliphatic carbonate monomers with reactive pentafluorophenyl (PFP) esters. First, block copolymers are acquired via cationic ring opening polymerization (CROP) onto polyethylene glycol (PEG). Upon self‐assembly in ethanol, the micelles’ core is cationically core‐crosslinked, and the resulting fully hydrophilic particles exhibit sizes of ≈20 nm, also upon loading with CpG‐ODN. In vitro, they promote intracellular delivery devoid of carrier‐related toxicities, while retaining the immune stimulatory properties of the TLR agonist cargo. In vivo, the nanogels reduce systemic liver immune responses and remain near the injection site. Additionally, delivery into cDC1 (conventional dentritic cells type 1) antigen‐presenting cells, which are highly relevant for antitumoral T‐cell immune responses, is confirmed. Altogether, cationic, core‐crosslinked polycarbonate nanogels show promise for nucleic acid delivery, showcasing controlled immunostimulatory cargo delivery and an enhanced hydrolytic biodegradability profile, highly valuable for cancer immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI